ADENTRA (TSE:ADEN) Price Target Cut to C$44.00 by Analysts at CIBC

ADENTRA (TSE:ADENGet Free Report) had its price target cut by stock analysts at CIBC from C$49.00 to C$44.00 in a research note issued to investors on Monday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock.

ADEN has been the subject of several other research reports. National Bankshares decreased their price objective on shares of ADENTRA from C$60.00 to C$53.00 and set an “outperform” rating for the company in a research note on Monday. Raymond James set a C$60.00 price objective on shares of ADENTRA and gave the company a “strong-buy” rating in a research note on Friday, December 20th. Finally, Cormark decreased their price objective on shares of ADENTRA from C$55.00 to C$46.00 in a research note on Monday. Six investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $48.13.

View Our Latest Report on ADEN

ADENTRA Price Performance

TSE ADEN opened at $27.81 on Monday. ADENTRA has a 1 year low of $27.37 and a 1 year high of $45.25. The company has a market capitalization of $491.02 million, a PE ratio of 9.48 and a beta of 1.57. The company has a fifty day moving average of $33.70 and a two-hundred day moving average of $37.60.

ADENTRA Company Profile

(Get Free Report)

ADENTRA Inc engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets in Canada and the United States. It offers doors, decorative surfaces, moldings, stair parts, hardwood lumber, hardwood plywood, composite panels, and other building products to industrial manufacturers, home builder distribution yards, and home centers.

See Also

Analyst Recommendations for ADENTRA (TSE:ADEN)

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.